The day's discussion will focus on how the remarkable confluence of theory and reality will pay real dividends for the biotech/ life science ventures now and in the coming years. Some of the topics planned to be discussed -

• Global Outlook for Biotech & Life Science Investment
• What are VC's looking for in a Biotechnology/ Life Sciences venturs
• How technology will change the future of medicine (Information based medicines)
• Real life winning strategies for Biotech / Life Sciences companies
• Biotech and Life Science in New York tristate area
• Early stage funding issues for Biotech and Life Science ventures
• Implications of strategic partnerships with big Pharma companies.
• How to choose venture caplitalists as partners, beyond money.
• How to value a Biotech venture.
• Hiring and compensation of Biotech executives.
• Exit strategy - M&A and IPO environment
• Incentives, tax subsidies, labor laws, scientific pools for biotech companies around the world.
• Genomic mapping and its implications for the future of biotechnology ventures
• Personalized medicine and the future
• The confluence of Nanotechnology and Biotech/ Life Sciences and new opportunities.